1. Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. (5th April 2018) Authors: Abou-Alfa, G K; Qin, S; Ryoo, B -Y; Lu, S -N; Yen, C -J; Feng, Y -H; Lim, H Y; Izzo, F; Colombo, M; Sarker, D; Bolondi, L; Vaccaro, G; Harris, W P; Chen, Z; Hubner, R A; Meyer, T; Sun, W; Harding, J J; Hollywood, E M; Ma, J Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗